In addition, androgen downregulation of miR‐760 was able to regulate interleukin (IL)‐6 and then promote prostate cancer cell growth [63], and there was less expression of miR‐942 in high‐grade than in low‐grade prostate cancer cases at biopsy [64]. This evidence concerns the gene IL6 and prostate carcinoma.